Vasilii Tkachenko

Vasilii Tkachenko

Auto-generated profile, based on publicly available information

Vasilii Tkachenko

Loginov Moscow Clinical Scientific Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
EIEmil D. Isagulayn
Emil D. Isagulayn
VTVasily Tkachenko
Vasily Tkachenko
DSDenis Semenov
Denis Semenov
SASvetlana Asriyants
Svetlana Asriyants
EDEvgeny Dorokhov
Evgeny Dorokhov
ATAlexei Tomskiy
Alexei Tomskiy
Introduction. Postherpetic neuralgia (PHN) is a severe condition that remains a challenge to treat. Spinal cord stimulation (SCS) is used in cases of insufficient efficacy of conservative treatment. However, in contrast to many other neuropathic pain syndromes, there is a huge problem in reaching long-term stable pain relief in patients with PHN using conventional tonic SCS. The objective of this article was to present a review of the current management strategies of PHN, their efficacy, and safety. Materials and Methods. We searched for articles containing the keywords spinal cord stimulation AND postherpetic neuralgia, high-frequency stimulation AND postherpetic neuralgia, burst stimulation AND postherpetic neuralgia and dorsal root ganglion stimulation AND postherpetic neuralgia in Pubmed, Web of Science, and Scopus databases. The search was limited to human studies published in the English language. There were no publication period limitations. Bibliographies and references of selected publications on neurostimulation for PHN were further manually screened. The full text of each article was studied once the abstract was analyzed by the searching reviewer and found appropriate. The initial search yielded 115 articles. Initial screening based on abstract and title allowed us to exclude 29 articles (letters, editorials, and conference abstracts). The full-text analysis allowed us to exclude another 74 articles (fundamental research articles, research utilizing animal subjects, and systemic and nonsystemic reviews) and results of PHN treatment presented with other conditions, leaving 12 articles for the final bibliography. Results. 12 articles reporting on the treatment of 134 patients with PHN were analyzed, with a disproportionally large amount of traditional SCS treatment than that to alternative SCS: DRGS (13 patients), burst SCS (1 patient), and high-frequency SCS (2 patients). Long-term pain relief was achieved in 91 patients (67.9). The mean VAS score improvement was 61.4 with a mean follow-up time of 12.85months. Although the number of patients in alternative SCS studies was very limited, almost all of them showed good responses to therapy with more than 50 VAS improvement and reduction of analgesic dosage. The article contains a review analysis of 12 articles concerning the current methods of treatment for postherpetic neuralgia including conservative treatment, spinal cord stimulation, and novel neuromodulation strategies. Available information on the pathophysiology of PHN and the effect or stimulation on its course, together with a number of technical nuances concerning various types of neurostimulation are also elucidated in this article. A number of alternative invasive treatments of PHN are also discussed. Conclusions. Spinal cord stimulation is an established treatment option for patients with pharmacologically resistant PHN. High-frequency stimulation, burst stimulation, and dorsal root ganglion stimulation are promising options in the management of PHN due to the absence of paresthesias which can be painful for patients with PHN. But more research is still required to recommend the widespread use of these new methods.

1 January 2021 in Russian Journal of Pain
Verified
Journal Article
Closed access
VTV.D. Tkachenko
V.D. Tkachenko
IPI.V. Portnyagin
I.V. Portnyagin
KGK.V. Goryacheva
K.V. Goryacheva
Боль в спине — одна из ведущих жалоб при обращении к неврологу лиц трудоспособного и пожилого возраста. Спонтанный регресс болевого синдрома в течение 6 нед наблюдается у 50% пациентов. Остальные случаи требуют активного медицинского вмешательства. Несмотря на обилие обезболивающих и нестероидных противовоспалительных препаратов, не всегда удается достичь адекватного купирования боли. Один из самых распространенных источников хронической боли в спине — фасеточный сустав. Наиболее безопасным и эффективным методом лечения является радиочастотная денервация фасеточных суставов. В обзоре представлены современные данные об эффективности и безопасности применения радиочастотной денервации у пациентов с болью в спине, обусловленной поражением фасеточных суставов, а также об изменениях качества жизни таких пациентов.

27 June 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
VTV.D. Tkachenko
V.D. Tkachenko
EKE.A. Korabelnikova
E.A. Korabelnikova
The purpose of the study: to assess objective and subjective sleep indicators in patients with chronic tension headache and their change during therapy. Material and methods. The study included 65 patients with chronic tension headache and insomnia. The assessment was conducted using headache questionnaires (headache VAS, headache diary, HIT-6, pain catastrophization scale), sleep quality questionnaires (Pittsburgh Sleep Quality Index (PSQI), sleep quality VAS), psychometric testing (Beck Depression Scale, Sheehan Anxiety Scale), a central sensitization questionnaire, and polysomnography. Patients were divided into two groups: patients of group 1 received prophylactic treatment with a drug for relief of insomnia symptoms and recommendations for sleep hygiene according to clinical guidelines, and patients of group 2 received only a drug for prophylactic treatment of headache. Results. In the group with insomnia treatment, the duration of the S3 phase of slow-wave sleep increased from 31.5 (27;36) to 47 (42;49) minutes and the subjective duration of sleep from 360±90 to 453.33±66.14 minutes, the severity of insomnia PSQI score decreased from 13 (10;15) to 7 (5;10) points, the frequency of headache reduced from 20.00 [17.00; 24.00] to 8.00 [5.00; 11.00] days and the pain intensity VAS decreased from 7.00 [6.00; 7.00] to 4.00 [3.00; 6.00] points, the anxiety severity according to the Sheehan Anxiety Scale decreased from 43 [26;51] to 19 [16;34 ] points and depression severity according to the Beck Depression Scale reduced from 14 [12;18] to 7 [6;10.5] points. Conclusion. Diagnosis and treatment of insomnia in patients with chronic tension headaches is an important strategy in managing this group of patients. This strategy allows not only to improve the objective and subjective sleep parameters but also to reduce the headache and the severity of comorbidities.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
EKE.A. Korabelnikova
E.A. Korabelnikova
VTV.D. Tkachenko
V.D. Tkachenko
Исследования показывают высокую частоту коморбидности инсомнии и ночных кошмаров (НК), которые отягощают и приводят к хронизации друг друга. Механизмы их взаимовлияния различны: инсомния меняет характер сновидений как опосредованно через характерную для нее эмоциональную гиперактивацию, так и вследствие частых пробуждений. Вместе с тем частые повторяющиеся неприятные и устрашающие сновидения могут сами по себе увеличивать частоту ночных пробуждений и ухудшить качество сна. Коморбидность инсомнии и НК должна учитываться при выборе терапевтической тактики у данной категории пациентов. Приоритетными являются препараты, не вызывающие в качестве побочного эффекта НК, а также психотерапия.

1 January 2026 in Open Medicine
Verified
Journal Article
Open access
EKElena Korabelnikova
Elena Korabelnikova
VTVasilii Tkachenko
Vasilii Tkachenko
ADAlexey B. Danilov
Alexey B. Danilov
ABAnastasiia Badaeva
Anastasiia Badaeva
LRLuay Rashan
Luay Rashan
VITTORIO CALABRESEVITTORIO CALABRESE
VITTORIO CALABRESE
Objectives: Emerging literature data indicate insomnia as an risk factor for headache or migraine onset. It is generally recognized that headache and insomnia represent very common and major complaints worldwide, while finding exisit that indicate a symmetrical association, with headache being more associated with insomnia than the other way around. Therefore, in the association of headache and insomnia, other factors associated with headache or migraine probably play a role, as well. The aim of the study was to evaluate the clinical and pathogenetic relationships between insomnia and chronic tension-type headache (CTTH). Methods: A prospective cohort study included 65 patients with CTTH and comorbid chronic insomnia. Participants underwent clinical evaluation, assessment of headache severity (VAS, HIT-6), insomnia (PSQI, ISI), emotional state (Beck, Sheehan scales), and quality of life (SF-12). A subset (n=17) underwent polysomnography (PSG). Results: All patients reported poor sleep quality. A significant discrepancy was found between subjective sleep perception and objective PSG data (p<0.001). Patients with more severe insomnia had significantly higher levels of anxiety (p<0.001), depression (p=0.025), central sensitization (p<0.001), and lower quality of life (p<0.002). Correlation analysis revealed that worse sleep parameters (e.g., reduced REM, increased wakefulness) were associated with higher headache impact, emotional distress, and central sensitization, particularly in the mild insomnia group. Conclusions: Insomnia in CTTH patients exacerbates the condition not primarily by intensifying pain itself, but by amplifying its negative impact on emotional state and quality of life, and by strengthening the interconnections between various clinical and psychophysiological manifestations. Treating insomnia is crucial for improving overall patient well-being and pain tolerance.

23 November 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VTV. D. Tkachenko
V. D. Tkachenko
SMS. A. Makarov
S. A. Makarov
ЕКЕ. А. Корабельникова
Е. А. Корабельникова
Introduction. Chronic tension headache and insomnia are a common mutually aggravating pathology. Drugs used to treat these nosologies most often worsen the course of the concomitant disease.Objective. To evaluate the effect of insomnia correction on the intensity and frequency of headachesMaterials and methods. The study involved 27 patients (25 women, 2 men) with chronic tension-type headache and sleep disorders. The median age was 43 ± 14.8 years. In accordance with the purpose of the study, the clinical group was divided into 2 subgroups. The first group was treated with venlafaxine and doxylamine, the patients of the second group received only venlafaxine treatment. The assessment was carried out before the start of treatment and 8 weeks after, using visual analogue scales for headache, sleep, health status, assessing the severity of insomnia using the Morin scale and the Pittsburgh Sleep Quality Inventory (PSQI), assessing the emotional state using the Sheehan anxiety and Beck depression scales and polysomnography.Results. In subgroup 1, which received correction of insomnia, there was a significant decrease in the number of days with headache (from 20 to 10, p = 0.002), pain intensity according to VAS (from 7 to 6, p = 0.01) and VAS sleep (from 6 to 4 points, p = 0.003). In the group without correction of insomnia, the number of days with headaches significantly decreased (from 15 to 12, p = 0.01), changes in the severity of headache according to VAS (from 7.5 to 6, p = 0.13) and sleep quality (from 6 to 7.5, p = 0.38) did not have a statistically significant difference. According to the results of polysomnography, patients who received correction of insomnia had an increase in the duration of slow-wave sleep by 12 minutes (p = 0.02), while in patients from the second subgroup by 4 minutes (p = 0.68).Conclusions. The use of a combination of venlafaxine and doxylamine in the first stages of treatment of patients with chronic tension-type headache and insomnia has an advantage over standard therapy. Combination therapy can reduce the intensity and frequency of headaches and improve sleep quality.